Bank Of New York Mellon Corp Vaxart, Inc. Transaction History

Bank Of New York Mellon Corp

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.75 - $2.24 $337,480 - $1.01 Million	449,974 New	449,974 $431,000
Q3 2022 Nov 14, 2022	BUY	$2.09 - $4.5 $88,898 - $191,407	42,535 Added 10.05%	465,646 $1.02 Million
Q2 2022 Aug 15, 2022	SELL	$2.7 - $5.28 $16,194 - $31,669	-5,998 Reduced 1.4%	423,111 $1.48 Million
Q1 2022 May 11, 2022	BUY	$4.29 - $6.64 $94 - $146	22 Added 0.01%	429,109 $2.16 Million
Q4 2021 Feb 11, 2022	BUY	$5.77 - $7.96 $31,284 - $43,159	5,422 Added 1.28%	429,087 $2.69 Million
Q3 2021 Nov 12, 2021	BUY	$6.67 - $9.8 $258,008 - $379,083	38,682 Added 10.05%	423,665 $3.37 Million
Q2 2021 Aug 11, 2021	BUY	$5.06 - $10.78 $482,885 - $1.03 Million	95,432 Added 32.96%	384,983 $2.88 Million
Q1 2021 May 13, 2021	SELL	$5.64 - $23.33 $31,042 - $128,408	-5,504 Reduced 1.87%	289,551 $1.75 Million
Q4 2020 Feb 09, 2021	BUY	$3.5 - $7.98 $462,626 - $1.05 Million	132,179 Added 81.15%	295,055 $1.68 Million
Q3 2020 Nov 12, 2020	BUY	$4.78 - $16.97 $181,984 - $646,081	38,072 Added 30.51%	162,876 $1.08 Million
Q2 2020 Aug 12, 2020	BUY	$1.68 - $8.85 $139,601 - $735,399	83,096 Added 199.23%	124,804 $1.1 Million
Q1 2020 May 06, 2020	BUY	$0.34 - $2.87 $14,180 - $119,701	41,708 New	41,708 $73,000

110

37.6M

188K

180K

Ticker VXRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,506,000
Market Cap $73.4M
Description
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.